Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 10, 2005. The report details a share repurchase transaction executed under shareholder authority granted at the Annual General Meeting on May 17, 2004, and discloses changes in directors' interests related to employee benefit plans.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial data disclosed relates to the share repurchase transaction:
- Shares Purchased: 740,000 Ordinary Shares
- Purchase Date: May 9, 2005
- Price per Share: 1,341.684 pence
- Treasury Shares Held Post-Transaction: 87,823,000
- Shares in Issue (excluding treasury): 5,854,342,191
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 740,000 shares for treasury. Additionally, the filing notes changes in the number of American Depositary Receipts (ADRs) held by the GlaxoSmithKline US Retirement Savings Plan, which increased from 18,118,100 to 18,168,570 due to fund movements on May 6, 2005, at an average price of $50.94. A separate transaction involved the transfer of 8,012 Ordinary Shares from the GlaxoSmithKline Employee Trust to participants in the SmithKline Beecham Employee Share Option Plan 1991.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities.
Investor Verification Checklist
- Verify the total cost of the 740,000 share repurchase against the reported price of 1,341.684 pence per share.
- Confirm the updated total share count (5,854,342,191 in issue) in subsequent filings.
- Review the impact of the 8,012 share transfer from the GSK Trust on the Employee Share Option Plan 1991.
- Check for any additional share buyback activity under the authority granted at the May 17, 2004 AGM.